Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1057-1063

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elinder, L. S.
Right arrow Articles by Walldius, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elinder, L. S.
Right arrow Articles by Walldius, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Antioxidants
*Cholesterol
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1057-1063.)
© 1995 American Heart Association, Inc.


Articles

Probucol Treatment Decreases Serum Concentrations of Diet-Derived Antioxidants

Liselotte Schäfer Elinder; Karin Hådell; Jan Johansson; Jørgen Mølgaard; Ingar Holme; Anders G. Olsson; Göran Walldius

From the Department of Internal Medicine, King Gustaf V Research Institute, Karolinska Institute, Stockholm, Sweden (L.S.E., J.J., G.W.); the Dietetics Department, Karolinska Hospital, Stockholm, Sweden (K.H.); the Research Center of General Medicine, North West Health Board, Stockholm County Council, Sweden (J.J.); the Department of Internal Medicine, University Hospital, Linköping, Sweden (J.M., A.G.O.); and The Life Insurance Companies Institute for Medical Statistics, Ullevål Hospital, Oslo, Norway (I.H.).

Correspondence to Liselotte Schäfer Elinder, Department of Medical Biochemistry and Biophysics, Karolinska Institute, S-171 77 Stockholm, Sweden.

Abstract The effect of probucol, which is both a cholesterol-lowering drug and an antioxidant, on the serum concentrations of diet-derived antioxidants vitamin E, ß-carotene, lycopene, and vitamin A was studied in 303 hypercholesterolemic subjects. In a 3-year, double-blind, randomized trial we investigated to determine whether combined treatment with diet, cholestyramine, and probucol could reduce the progression of femoral atherosclerosis. Serum and lipoprotein antioxidant levels were measured by reverse-phase high-performance liquid chromatography. Cholestyramine significantly lowered serum concentrations of vitamin E by 7%, ß-carotene by 40%, and lycopene by 30% (all P<.001) due to impairment of gastrointestinal absorption and to serum cholesterol lowering. Probucol reduced serum vitamin E by 14% (P<.001) secondary to cholesterol and triglyceride lowering. The carotenoids were reduced by probucol by 30% to 40% (P<.001) most probably due to reductions in lipoprotein particle size and to competition with these substances for incorporation into VLDL during its assembly in the liver. This study shows that the use of a lipid-soluble antioxidant and cholesterol-lowering drug may have unfavorable effects on blood levels of diet-derived antioxidants.


Key Words: hypercholesterolemia • cholestyramine • probucol • vitamin E • ß-carotene




This article has been cited by other articles:


Home page
J. Nutr.Home page
C. W. Hadley, S. K. Clinton, and S. J. Schwartz
The Consumption of Processed Tomato Products Enhances Plasma Lycopene Concentrations in Association with a Reduced Lipoprotein Sensitivity to Oxidative Damage
J. Nutr., March 1, 2003; 133(3): 727 - 732.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
T. W.-M. Boileau, A. C. Boileau, and J. W. Erdman Jr
Bioavailability of all-trans and cis-Isomers of Lycopene
Experimental Biology and Medicine, November 1, 2002; 227(10): 914 - 919.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. Cynshi, Y. Kawabe, T. Suzuki, Y. Takashima, H. Kaise, M. Nakamura, Y. Ohba, Y. Kato, K. Tamura, A. Hayasaka, et al.
Antiatherogenic effects of the antioxidant BO-653 in three different animal models
PNAS, August 18, 1998; 95(17): 10123 - 10128.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
D. A. Bird, R. K. Tangirala, J. Fruebis, D. Steinberg, J. L. Witztum, and W. Palinski
Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice
J. Lipid Res., May 1, 1998; 39(5): 1079 - 1090.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y.-J. Wu, C.-Y. Hong, S.-J. Lin, P. Wu, and M.-S. Shiao
Increase of Vitamin E Content in LDL and Reduction of Atherosclerosis in Cholesterol-Fed Rabbits by a Water-Soluble Antioxidant-Rich Fraction of Salvia miltiorrhiza
Arterioscler. Thromb. Vasc. Biol., March 1, 1998; 18(3): 481 - 486.
[Abstract] [Full Text] [PDF]